Ronald Cornet
Associate Professor & Principal Investigator
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Ronald Cornet is an Associate Professor and Principal Investigator at Amsterdam UMC, located in the Netherlands. His research primarily focuses on health data harmonization, eHealth interventions, and the application of standardized vocabularies in clinical research. Recent publications include studies on the impact of eHealth interventions in melanoma patients and the ethical implications of federated learning in data sharing. He is dedicated to improving clinical decision-making through structured problem lists in electronic health records.
Articles (17)
Year:
2025
Year:
2025
The conect4children (c4c) initiative was established to facilitate the development of new drugs and other therapies for paediatric patients. It is widely recognised that there are not enough medicines tested for all relevant ages of the paediatric population. To overcome this, it is imperative that clinical data from different sources are interoperable and can be pooled for larger post hoc studies. c4c has collaborated with the Clinical Data Interchange Standards Consortium (CDISC) to develop cross-cutting data resources that build on existing CDISC standards in an effort to standardise paediatric data. The natural next step was an extension to disease-specific data items. c4c brought together several existing initiatives and resources relevant to disease-specific data and analysed their use for standardising disease-specific data in clinical trials. Several case studies that combined disease-specific data from multiple trials have demonstrated the need for disease-specific data standardisation. We identified three relevant initiatives. These include European Reference Networks, European Joint Programme on Rare Diseases, and Pistoia Alliance. Other resources reviewed were National Cancer Institute Enterprise Vocabulary Services, CDISC standards, pharmaceutical company-specific data dictionaries, Human Phenotype Ontology, Phenopackets, Unified Registry for Inherited Metabolic Disorders, Orphacodes, Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP), and Observational Medical Outcomes Partnership. The collaborative partners associated with these resources were also reviewed briefly. A plan of action focussed on collaboration was generated for standardising disease-specific paediatric clinical trial data. A paediatric data standards multistakeholder and multi-project user group was established to guide the remaining actions—FAIRification of metadata, a Phenopackets pilot with RDCA-DAP, applying Orphacodes to case report forms of clinical trials, introducing CDISC standards into European Reference Networks, testing of the CDISC Pediatric User Guide using data from the mentioned resources and organisation of further workshops and educational materials.
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Collaborators (15)
Barbara Wollersheim
Antoni van Leeuwenhoek Nederlands Kanker Instituut
Johnblack K Kabukye
KTH Royal Institute of Technology
Julius Jacobsen
Queen Mary University of London
Giorgio Reggiardo
Head
Consorzio per Valutazioni Biologiche e Farmacologiche
Peter 't Hoen
Professor of Bioinformatics
Radboud Universitair Medisch Centrum
Martijn Kersloot
Assistant Professor
Academic Medical Center
Szymon Wilk
Assistant Professor
Poznan University of Technology
Peter Robinson
Professor of Computational Biology
The Jackson Laboratory for Genomic Medicine
Marieke Bak
University of Amsterdam
Daniel Rueckert
Director, Alexander von Humboldt Professor for AI
Technical University of Munich
Ramona L. Walls
Assistant Research Professor
University of Arizona
Dave A. Dongelmans
-
Volker Straub
Newcastle University
Claudia Pansieri
Istituto di Ricerche Farmacologiche Mario Negri
Anando Sen
Northumbria University
Make your next move.
Prepare your application
Review drafts before you send them.